Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for an AIDS vaccine.

M Girard1

  • 1Pasteur Vaccins, Marnes La Coquette, France.

Cancer Detection and Prevention
|January 1, 1990
PubMed
Summary

Developing an effective HIV vaccine is challenging due to the virus's genetic diversity and ability to evade immune responses. However, preliminary data suggest that neutralizing antibodies and specific vaccine types may offer protection, fostering hope for future HIV vaccine development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complete nucleotide sequence of the genomic RNA of a French isolate of Pepino mosaic virus (PepMV). Brief report.

Archives of virology·2002
Same author

The influence of long emersion on biota, ammonium fluxes and nitrification in intertidal sediments of Marennes-Oléron Bay, France.

Marine environmental research·2002
Same author

Investing in CAD/CAM.

Journal of dental technology : the peer-reviewed publication of the National Association of Dental Laboratories·2002
Same author

Inositol hexakisphosphate-mediated regulation of glutamate receptors in rat brain sections.

Hippocampus·2002
Same author

Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10.

Human molecular genetics·2001
Same author

DNA vaccine protection against challenge with simian/human immunodeficiency virus 89.6 in rhesus macaques.

Developments in biologicals·2001

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Human Immunodeficiency Virus (HIV) presents significant challenges for vaccine development.
  • HIV exhibits substantial genetic variability, hindering the efficacy of neutralizing antibodies against diverse isolates.
  • The virus can spread cell-to-cell, evading humoral immunity, and establish long-term latency as a provirus.

Purpose of the Study:

  • To review the key obstacles in developing an effective HIV vaccine.
  • To explore the potential of neutralizing antibodies and novel vaccine strategies for HIV prevention.

Main Methods:

  • Review of existing literature on HIV immunology and vaccine research.
  • Analysis of HIV's genetic diversity and mechanisms of immune evasion.
  • Examination of preliminary data on antibody responses and vaccine efficacy in related viruses like SIV (Simian Immunodeficiency Virus).

Main Results:

  • HIV's genetic variability and cell-to-cell transmission impede the development of broadly neutralizing antibodies.
  • The HIV envelope glycoprotein is poorly immunogenic in primates, inducing weak neutralizing antibody titers.
  • Preliminary evidence suggests neutralizing antibodies may be protective, and certain vaccine approaches show promise.

Conclusions:

  • Despite considerable difficulties, the development of an HIV vaccine remains a critical goal.
  • Further research into neutralizing antibodies and vaccine-induced protection is warranted.
  • Findings offer cautious optimism for the eventual development of a protective HIV vaccine.

Related Experiment Videos